Standard Biotools Inc. logo

Standard Biotools Inc. (LAB)

Market Closed
3 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
1. 35
-0.02
-1.46%
$
451.99M Market Cap
- P/E Ratio
0% Div Yield
860,400 Volume
0 Eps
$ 1.37
Previous Close
Day Range
1.31 1.39
Year Range
0.92 2.41
Want to track LAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 23 days
Standard BioTools to Participate in Upcoming Investor Conferences

Standard BioTools to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that its management team will participate in the following investor conferences in the month of November: UBS Global Healthcare Conference on November 12 th , 2024 President and CEO, Michael Egholm, PhD, will participate in a corporate presentation on Tuesday, November 12, 2024, at 1:15 p.m.

Globenewswire | 8 months ago
Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript

Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript

Standard BioTools Inc. (NASDAQ:LAB ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants David Holmes - IR Michael Egholm - President & CEO Alex Kim - Chief Operating Officer & Interim-CFO Conference Call Participants Matt Stanton - Jefferies Operator Good day and welcome to the Standard BioTools Inc Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.

Seekingalpha | 8 months ago
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates

Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates

Standard BioTools (LAB) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.15 per share a year ago.

Zacks | 8 months ago
Standard BioTools Reports Third Quarter 2024 Financial Results

Standard BioTools Reports Third Quarter 2024 Financial Results

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company”) today announced unaudited interim financial results for the third quarter ended September 30, 2024.

Globenewswire | 8 months ago
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report third quarter 2024 financial results on Wednesday, October 30, 2024, after the close of the market.

Globenewswire | 8 months ago
GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENT

GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENT

MEXICO CITY , Sept. 10, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B.

Prnewswire | 9 months ago
Standard BioTools And 2 Other Penny Stocks Executives Are Buying

Standard BioTools And 2 Other Penny Stocks Executives Are Buying

The Dow Jones index closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

Benzinga | 10 months ago
Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying

Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying

The Dow Jones index closed higher by around 0.2% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

Benzinga | 10 months ago
Standard BioTools to Participate in Upcoming Investor Conferences

Standard BioTools to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), today announced that its management team will participate in the following investor conferences in the month of August: Canaccord Genuity 44th Annual Growth Conference on August 13th, 2024 President and CEO, Michael Egholm, PhD, will participate in a fireside chat on Tuesday, August 13, 2024, at 9:00 a.m.

Globenewswire | 11 months ago
Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript

Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript

Standard BioTools Inc. (NASDAQ:LAB ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants David Holmes - IR Michael Egholm - President and CEO Jeff Black - CFO Conference Call Participants Matt Stanton - Jefferies Dan Brennan - TD Cowen Paul Knight - KeyBanc Operator Good day and welcome to the Standard BioTools Second Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.

Seekingalpha | 11 months ago
Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates

Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates

Standard BioTools (LAB) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.14 per share a year ago.

Zacks | 11 months ago
Standard BioTools Announces Senior Leadership Changes

Standard BioTools Announces Senior Leadership Changes

Alex Kim, Chief Operating Officer and Standard BioTools Co-Founder, to Serve as interim Chief Financial Officer Following Departure of Jeffrey Black on August 31, 2024 Industry Veteran Sean Mackay Named Chief Business Officer SOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that Jeffrey Black, Chief Financial Officer, will resign from the Company, effective August 31, 2024, to accept an opportunity at another public company.

Globenewswire | 11 months ago
Loading...
Load More